SCHEMBL5513640

SCHEMBL5513640

NOCCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27747996 0.97 ODC1 (0.45)
SCHEMBL28822385 0.97 ODC1 (0.45)
Ammonia Solution, Strong SCHEMBL8863583 0.97
SCHEMBL12230876 0.97
SCHEMBL8091891 0.97
Hydrochloric Acid SCHEMBL31712150 0.94
SCHEMBL17770697 0.90
SCHEMBL1038811 0.90
Hydrochloric Acid SCHEMBL3889714 0.87
SCHEMBL23128499 0.85 GAA (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105051133-A Composition for forming cured film, alignment material, and phase difference material NISSAN CHEMICAL IND LTD 2015-11-11 CN disclosed
WO-2013106535-A9 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS, INC. (US) 2014-09-04 WO disclosed
EP-1301472-B1 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER LAMBERT CO (US) 2014-03-26 EP disclosed
WO-2013106535-A1 IRAK INHIBITORS AND USES THEREOF NIMBUS IRIS, INC. (US) 2013-07-18 WO disclosed
US-7173059-B2 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same AGOURON PHARMACEUTICALS, INC. (US) 2007-02-06 US disclosed
CN-1819993-A Intermediates for the synthesis of HIV-protease inhibitors and processes for their preparation PFIZER (US) 2006-08-16 CN disclosed
EP-1633704-A2 INTERMEDIATES USEFUL IN THE SYNTHESIS OF HIV-PROTEASE INHIBITORS AND METHODS FOR PREPARING THE SAME PFIZER INC. (US) 2006-03-15 EP disclosed
US-20050250949-A1 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same AGOURON PHARMACEUTICALS INC. 2005-11-10 US disclosed
WO-2004099129-A2 INTERMEDIATES USEFUL IN THE SYNTHESIS OF HIV-PROTEASE INHIBITORS AND METHODS FOR PREPARING THE SAME PFIZER INC. (US) 2004-11-18 WO disclosed